mhealth and wearables: where do we go? - cib pharma · •mhealth can save according to pwc in 2017...
TRANSCRIPT
mHealth and wearables: where do we go?
Luc Baert
CEO Medical Web Services05/06/2015 CIB 45+1
Luc Baert
CEO of Medical Web Services
CEO of Medipim
Member of TSC Recip-e
Security consultant Recip-e
IOTInternet
Of
Things
mHealth
Healthcare
eHealth
mHealth
Presentatie Pieter Van Herck (Voka)
Apple Health with IOS 8
Apps by device
Triangle
Any moment, any place
GSM
Tablets
Devices/sensors
Data
Data
Manufacturer
External partner
Care professionals
Service providers
…
Patient
Social health networks
Studie Iminds28/05/2015
http://www.iminds.be/nl/nieuws/20150528_pr_wearables
Wearables / Apps
• Data from specific sensors• Diabetes
• Exercise
• Heart
• …
• Continuous flow of data
Algorithms !!!!
VOKA Health: WHY?
Why?
• The U.S. healthcare system could reduce costs by nearly $200 billion over the next 25 years by using • remote monitoring technology in patients with of congestive heart
failure, chronic obstructive pulmonary disease, and chronic wounds or skin ulcers
Medicine on the Net.
Why?
• mHealth can save according to PWC in 2017 potentially 99 billion in health care spending in the EU.
• The biggest saving • Well-being and prevention (69 billion euros),
• Management / monitoring (32 billion euros).
• The additional personnel costs to support mHealth: 6.2 billion euros.
The big technology companies
https://plus.google.com/+LarryPage/posts/Lh8SKC6sED1
Issues
• Data protection – security
• mHealth role in healthcare systems and equal access
• Interoperability – standardization
• Reimbursement models
• Liability (accuracy)
• Acceptation by HCP
• Poor discoverability
• Unregulated status of health apps
“Mobile medical apps are medical devices that are
• mobile apps,
• meet the definition of a medical device
• are an accessory to a regulated medical device or transform a mobile platform into a regulated medical device.”
http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/Guidan
ceDocuments/UCM263366.pdf
Regulation
To do
Legal
1. Dataprotection, privacy and the use of big data
2. (Inter)nationale regulation and liability
Technical
3. Quality, , accessibility and patient safety
4. Technology and interoperability
Financial
5. Financing and business models
Governmental
6. Supportive in mHealth
How can pharma benefit?
• Contraints
• Patent protection expiring
• Absence of novel blockbusters
• Increasing costs R&D
• Intensifying price pressures
Reimbursement ???
Survey: how to connectwith physicians?
What's pharma's impact on the mobile health app space?
Many of them are designed as companion apps for drugs and devices.
Potential for healthcare
• mHealth• Patient-focused healthcare
• Integrated network healthcare
• Shift towards prevention
• More efficient and sustainable healthcare
Technology is enabler!
Studie Iminds 28/05/2015http://www.iminds.be/nl/nieuws/20150528_pr_wearables
Voka health Community: http://www.healthcommunity.be/
White paper Voka: http://www.healthcommunity.be/sites/default/files/u195/Whitepaper%20Health%20Community%20%27mHealth%27_lowres.pdf
